Pharma Journalist -

Aimmune Therapeutics announced its plans for the upcoming year to report top-line results in February from a pivotal phase 3 PALISADE trial of AR101 for peanut allergy following the…
Read More...

IT solutions to the global life sciences market, Instem announces the purchase of  Provantis preclinical software solution suite by  Guangdong Lewwin Pharmaceutical Research Institute…
Read More...

Octapharma USA declared Neil Herson to come on board to join as Senior VP of National Accounts and market access. Former ASD Healthcare, Neil possesses 25 years of global pharmaceutical…
Read More...

Novaliq announces randomizing patients in its SEECASE Phase 2 clinical trial of NOV03 for treating dry eye disease. Novaliq is a pharmaceutical company delivering drugs that transforms…
Read More...

SMi Reports:4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED AT SMI’s DRUG DISCOVERY CONFERENCE 2018 SMi’s Drug Discovery conference taking place on 21st and 22nd March…
Read More...

Mitochondrial organisations comprising of the The Foundation for Mitochondrial Medicine (FMM), MitoAction, the Mitochondrial Medicine Society (MMS) and the United Mitochondrial Disease…
Read More...

After successful completion of pre-clinical safety studies for MIV-818 which is Medivir AB’s liver targeted nucleotide prodrug for diagnosing hepatocellular carcinoma and other forms of…
Read More...

Clinical-stage Immunology Company asserted appointment of Sterna Biologicals as the Chief Executive Officer who has over 25 years of experience in life science specifically in areas of…
Read More...

Acercus pharmaceuticals declare exclusive distributor and license agreement with Innovus Pharmaceuticals. UriVarx is a Natural Health Product (NHP) that alleviates symptoms of…
Read More...

On having received $ 38 million Series A financing by Maxim Merchant Capital, Alveo technologies to embark on curation of efficient and cost-effective disease diagnostic devices aiding…
Read More...